173 related articles for article (PubMed ID: 16023752)
21. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles.
Noack A; Hause G; Mäder K
Int J Pharm; 2012 Feb; 423(2):440-51. PubMed ID: 22197758
[TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
23. Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity.
Kuntsche J; Koch MH; Fahr A; Bunjes H
Eur J Pharm Sci; 2009 Oct; 38(3):238-48. PubMed ID: 19664705
[TBL] [Abstract][Full Text] [Related]
24. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
Garcia-Fuentes M; Alonso MJ; Torres D
J Colloid Interface Sci; 2005 May; 285(2):590-8. PubMed ID: 15837476
[TBL] [Abstract][Full Text] [Related]
25. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
26. Chemical stability of phospholipid-stabilized supercooled smectic cholesteryl myristate nanoparticles.
Mengersen F; Bunjes H
Eur J Pharm Biopharm; 2012 Oct; 82(2):262-71. PubMed ID: 22750438
[TBL] [Abstract][Full Text] [Related]
27. Composite phospholipid-calcium carbonate microparticles: influence of anionic phospholipids on the crystallization of calcium carbonate.
Gopal K; Lu Z; de Villiers MM; Lvov Y
J Phys Chem B; 2006 Feb; 110(6):2471-4. PubMed ID: 16471842
[TBL] [Abstract][Full Text] [Related]
28. Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: a feasibility study.
Schoenitz M; Joseph S; Nitz A; Bunjes H; Scholl S
Eur J Pharm Biopharm; 2014 Apr; 86(3):324-31. PubMed ID: 23969160
[TBL] [Abstract][Full Text] [Related]
29. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
[TBL] [Abstract][Full Text] [Related]
30. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
Windbergs M; Strachan CJ; Kleinebudde P
J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
[TBL] [Abstract][Full Text] [Related]
31. The thermotropic phase behaviour and phase structure of a homologous series of racemic beta-D-galactosyl dialkylglycerols studied by differential scanning calorimetry and X-ray diffraction.
Mannock DA; Collins MD; Kreichbaum M; Harper PE; Gruner SM; McElhaney RN
Chem Phys Lipids; 2007 Jul; 148(1):26-50. PubMed ID: 17524381
[TBL] [Abstract][Full Text] [Related]
32. PEGylation of supercooled smectic cholesteryl myristate nanoparticles.
Mengersen F; Bunjes H
Eur J Pharm Biopharm; 2012 Jun; 81(2):409-17. PubMed ID: 22487056
[TBL] [Abstract][Full Text] [Related]
33. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
[TBL] [Abstract][Full Text] [Related]
34. Stimuli-responsive surface crystallization of phospholipids from bimodal colloidal particles.
Lestage DJ; Schleis DJ; Urban MW
Langmuir; 2004 Aug; 20(17):7027-35. PubMed ID: 15301484
[TBL] [Abstract][Full Text] [Related]
35. Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions.
Blümer C; Mäder K
Pharm Res; 2005 Oct; 22(10):1708-15. PubMed ID: 16180129
[TBL] [Abstract][Full Text] [Related]
36. Relationships between molecular structure and kinetic and thermodynamic controls in lipid systems. Part II: Phase behavior and transformation paths of SSS, PSS and PPS saturated triacylglycerols--effect of chain length mismatch.
Bouzidi L; Narine SS
Chem Phys Lipids; 2012 Jan; 165(1):77-88. PubMed ID: 22119325
[TBL] [Abstract][Full Text] [Related]
37. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
38. Multiple β Forms of Saturated Monoacid Triacylglycerol Crystals.
Takeguchi S; Sato A; Hondoh H; Aoki M; Uehara H; Ueno S
Molecules; 2020 Nov; 25(21):. PubMed ID: 33147818
[TBL] [Abstract][Full Text] [Related]
39. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of the model drug ubidecarenone into solid lipid nanoparticles.
Bunjes H; Drechsler M; Koch MH; Westesen K
Pharm Res; 2001 Mar; 18(3):287-93. PubMed ID: 11442266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
